HGV 0.00% 5.2¢ hygrovest limited

Ann: Haywood Securities Research Report, page-57

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 83 Posts.
    lightbulb Created with Sketch. 7
    I'm on board.

    Are the Buccal Patches still going through development processes?
    Can any further update be provided?
    Although still included on websites, the Buccal Patch development was not included on the 31/5/17 Investor Update of MMJ's current activities.

    Phytotech announced the Canigma Vaporiser Head of Agreement on 2/3/15, provided Canigma's estimated development timeframe, and began funding Canigma for its development.
    Although still included on websites as in development, the Vaporiser was not included on the 31/5/17 Investor Update advising MMJ's current activities.
    What is the status of the Canigma patent application for Vaporiser?
    Can you provide a general update of the Canigma pill-based Vaporiser development status?

    Reference - https://hotcopper.com.au/threads/an...ionary-vaporiser-device.2467882/#.WWFhtNR97s0
 
watchlist Created with Sketch. Add HGV (ASX) to my watchlist
(20min delay)
Last
5.2¢
Change
0.000(0.00%)
Mkt cap ! $10.93M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 75584 5.2¢
 

Sellers (Offers)

Price($) Vol. No.
5.3¢ 40272 2
View Market Depth
Last trade - 10.04am 21/10/2024 (20 minute delay) ?
HGV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.